Genetic risk factors for cervical cancer
- 作者U. Gyllensten; A. Beskow; M. Moberg; J. Rønnholm
- 卷第37卷
- 印刷ISSN0959-8049
- 文件大小160.42KB
- 发表时间2001
- DOI10.1016/s0959-8049(01)81012-1
Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer?Raja, S. G.; Salhiyyah, K.; Nagarajan, K. · Interactive CardioVascular and Thoracic Surgery · 2007
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancerMelcher, AA; Mort, D; Maughan, TS · British Journal of Cancer · 1996
Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancerM. A. Morgan; W. G. Lewis; T. D. L. Crosby; X. Escofet; S. A. Roberts; A. E. Brewster; T. J. Harvard; G. W. B. Clark · 2007
Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapyKnight, W. R. C.; Zylstra, J.; Van Hemelrijck, M.; Griffin, N.; Jacques, A. E. T.; Maisey, N.; Baker, C. R.; Gossage, J. A.; Largergren, J.; Davies, A. R. · BJS Open · 2017
SUN-LB655: Age and sex Related Variations in Body composition During Neoadjuvant Chemotherapy for Oesophageal CancerMiller, J.; Ramage, M.I.; Wigmore, S.J.; Skipworth, R.J. · Clinical Nutrition · 2019
2111 Response and survival in oesophageal cancer patients following neoadjuvant chemotherapy assessed by FDG-PETCT imagingY. Manikyam; S. Hughes; C. Harrison; C.L. Ng; D. Carey; A. Kennedy; J. McGuigan; K. McManus; M. Eatock · 2009
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancerGillies, R. S.; Middleton, M. R.; Blesing, C.; Patel, K.; Warner, N.; Marshall, R. E. K.; Maynard, N. D.; Bradley, K. M.; Gleeson, F. V. · European Radiology · 2012
Landsteiner Award. HLA epitope matchingP.I. TERASAKI; S. TAKEMOTO; M.S. PARK; B. CLARK · 1992
Reactions of tetrakis(trifluorophosphine)nickel(o)R.J. Clark; P.I. Hoberman; E.O. Brimm · 1965
EVALUATION OF BELZER AND COLLINS KIDNEY-PRESERVATION METHODSClark, E.A.; Opelz, G.; Mickey, M.R.; Terasaki, P.I. · 1973
The acceptability of smokeless tobacco products depends on nicotine levelsCruz-Cano, R.; Rangel-Gomez, M.; Van Wagoner, C.; Kidanu, A.; Brinkman, M.C.; Clark, P.I. · Addictive Behaviors Reports · 2019
Characterization of three different human T cell membrane antigens, two being present on T lymphocyte subpopulationsBilling, R.J.; Clark, B.; Terasaki, P.I. · 1980
Assignment<footref rid="foot01"><sup>1</sup></footref> of β-centractin (CTRN2) to human chromosome 2 bands q11.1→q11.2 with somatic cell hybrids and in situ hybridizationElsea, S.H.; Clark, I.B.; Juyal, R.C.; Meyer, D.J.; Meyer, D.I.; Patel, P.I. · Cytogenetic and Genome Research · 1999
Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)D.J. Girling; N. Thatcher; P.I. Clark; R.J. Stephens · 1996